A hypofractionated radiotherapy schedule with 57.75Gy in 21 fractions for T1-2N0 prostate carcinoma: Analysis of late toxicity and efficacy.
Kouloulias V, Zygogianni A, Kantzou I, Tolia M, Platoni K, Antypas C, Chaldeopoulos D, Pantelakos P, Siatelis A, Chrysofos M, Beli I, Dilvoi M, Georgakopoulos I, Sarris G, Kouvaris J, Kelekis N.
Kouloulias V, et al. Among authors: tolia m.
J BUON. 2014 Jul-Sep;19(3):763-9.
J BUON. 2014.
PMID: 25261664
Free article.